SASH3 and rectum adenocarcinoma: Meanwhile, low expression of SASH3 in cancer was observed in bladder urothelial carcinoma (BLCA), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), LUAD, lung squamous cell carcinoma (LUSC), and rectum adenocarcinoma (READ) (Figure 1A).